Suchergebnisse - "Rayón, Chelo"

PubPharm (10)

1

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

enthalten in: Blood | 2011

von Montesinos, P. | Rayón, C. | Vellenga, E. | +123

2

Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group

enthalten in: Blood | 2010

von Tallman, M. | Kim, H. | Montesinos, P. | +23

3

Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2010

von Montesinos, P. | González, J. | González, J. | +17

4

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients : further improvements in treatment outcome

enthalten in: Blood | 2010

von Sanz, M. | Montesinos, P. | Rayón, C. | +118

CommentIn: Nat Rev Clin Oncol. 2010 Sep;7(9):484. - PMID 20824904

5

Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

enthalten in: Haematologica | 2010

von Cervera, J. | Montesinos, P. | Hernández-Rivas, J. | +17

6

Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis

enthalten in: Haematologica | 2009

von Montesinos, P. | Díaz-Mediavilla, J. | Debén, G. | +18

CommentIn: Haematologica. 2010 Jan;95(1):171-2. - PMID 19815840

7

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy : characteristics, outcome, and prognostic factors

enthalten in: Blood | 2009

von Montesinos, P. | Bergua, J. | Vellenga, E. | +17

8

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin

enthalten in: Blood | 2008

von de la Serna, J. | Montesinos, P. | Vellenga, E. | +17

9

All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia

enthalten in: Blood | 2004

von Sanz, M. | Vellenga, E. | Rayón, C. | +12

10

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy : a multicenter study by the PETHEMA group

enthalten in: Blood | 2004

von Sanz, M. | Martín, G. | González, M. | +17

1
[1]